SIMVASTATIN (ZOCOR)

Course overview

Simvastatin is U.S. FDA-approved as an adjunct to diet to treat primary hypercholesterolemias, mixed hyperlipidemia, familial hypercholesterolemia, familial type 3 hyperlipoproteinemia, and hypertriglyceridemia; to reduce risk for cardiovascular events in patients at high risk; and to prevent stroke. This continuing education module is designed to give the reader/learner an increased understanding of simvastatin. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.